Skip to content


Hepatology, Medicine and Policy

What do you think about BMC? Take part in


Sort by
Previous Page Page 1 of 2 Next Page
  1. Content type: Review

    The 16 countries of the Eastern Europe and Central Asia (EECA) region are home to 6.6 million people in need of treatment for chronic hepatitis C virus (HCV) infection. Because of transformational change in HC...

    Authors: Ludmila Maistat, Natalija Kravchenko and Amulya Reddy

    Citation: Hepatology, Medicine and Policy 2017 2:9

    Published on:

  2. Content type: Research

    India is home to one in 14 of all chronic hepatitis B virus (HBV) cases, meaning that it is important to develop HBV interventions that are applicable in the Indian context. Vaccination is the foremost tool fo...

    Authors: Gourdas Choudhuri, Rajesh Ojha, T. S. Negi, Varun Gupta, Shipra Saxena, Arundhati Choudhuri, Sanjoy Pal, Jui Choudhuri and Alok Sangam

    Citation: Hepatology, Medicine and Policy 2017 2:10

    Published on:

  3. Content type: Debate

    The International AIDS Society convened the 3rd International HIV/Viral Hepatitis Co-Infection Meeting on 17 July 2016 as part of the pre-conference program preceding the 21st International AIDS Conference hel...

    Authors: Tongai G. Maponga, Rachel Matteau Matsha, Sébastien Morin, Andrew Scheibe, Tracy Swan, Isabelle Andrieux-Meyer, C. Wendy Spearman, Marina B. Klein and Jürgen Kurt Rockstroh

    Citation: Hepatology, Medicine and Policy 2017 2:8

    Published on:

  4. Content type: Research

    Comprehensive information on the incidence and duration of hepatitis C virus (HCV) infection for people who inject drugs (PWID) in Ireland is not available. We created an incidence curve of injecting drug use ...

    Authors: Anne Marie Carew, Niamh Murphy, Jean Long, Kate Hunter, Suzi Lyons, Cathal Walsh and Lelia Thornton

    Citation: Hepatology, Medicine and Policy 2017 2:7

    Published on:

  5. Content type: Roundtable discussion

    Hepatitis B is preventable and hepatitis C is treatable even if still at a high cost; most people who are infected with hepatitis B or C virus have not been screened yet and are unaware of their infections; an...

    Authors: David FitzSimons, Greet Hendrickx, Johannes Hallauer, Heidi Larson, Daniel Lavanchy, Ina Lodewyckx, Daniel Shouval, John Ward and Pierre Van Damme

    Citation: Hepatology, Medicine and Policy 2016 1:16

    Published on:

  6. Content type: Debate

    The treatment of hepatitis C has entered a new era since the advent of curative pharmaceuticals. As policy, government and civil society assemble in response, there are still gaps to be addressed. The Manifest...

    Authors: Eberhard Schatz, Katrin Schiffer, Mags Maher, Magdalena Harris, Xavier Major Roca, Mojca Maticic and Astrid Leicht

    Citation: Hepatology, Medicine and Policy 2016 1:14

    Published on:

  7. Content type: Research

    The human immunodeficiency virus (HIV) epidemic in Russia, driven by injection drug use, has seen a steady rise in the past two decades. Hepatitis C virus (HCV) infection is highly prevalent in people who inje...

    Authors: Judith I. Tsui, Stephen C. Ko, Evgeny Krupitsky, Dmitry Lioznov, Christine E. Chaisson, Natalia Gnatienko and Jeffrey H. Samet

    Citation: Hepatology, Medicine and Policy 2016 1:13

    Published on:

  8. Content type: Debate

    The inaugural World Hepatitis Summit was jointly convened by the World Health Organization (WHO) and the World Hepatitis Alliance and hosted by the Scottish Government and supported by Glasgow Caledonian Unive...

    Authors: Charles Gore, Stefan Wiktor, David Goldberg, Sharon Hutchinson, Jose Antonio Oñate Moreno and Raquel Peck

    Citation: Hepatology, Medicine and Policy 2016 1:12

    Published on:

  9. Content type: Research

    People who inject drugs (PWID) are disproportionately affected by both HIV and hepatitis C infection (HCV). Awareness of infection status is essential to ensure linkage to appropriate healthcare for those infe...

    Authors: Stine Nielsen, Martyna Gassowski, Benjamin Wenz, Norbert Bannert, Claus-Thomas Bock, Claudia Kücherer, R. Stefan Ross, Viviane Bremer, Ulrich Marcus and Ruth Zimmermann

    Citation: Hepatology, Medicine and Policy 2016 1:8

    Published on:

  10. Content type: Research

    HCV/HIV coinfection in people who inject drugs is a public health issue, which presents a variety of challenges to healthcare providers. The determinants of HCV/HIV coinfection in this population are nonethele...

    Authors: Anastasios Fotiou, Eleftheria Kanavou, Argyro Antaraki, Clive Richardson, Manina Terzidou and Anna Kokkevi

    Citation: Hepatology, Medicine and Policy 2016 1:9

    Published on:

  11. Content type: Research

    HIV co-infection exacerbates hepatitis C disease, increasing the risk of cirrhosis and hepatitis C-related mortality. Combination antiretroviral therapy (cART) is the current standard treatment for co-infected...

    Authors: Alexis Llewellyn, Mark Simmonds, Will L Irving, Ginny Brunton and Amanda J Sowden

    Citation: Hepatology, Medicine and Policy 2016 1:10

    Published on:

  12. Content type: Research

    India has a high burden of disease from hepatitis B virus (HBV), with 3.7 % point-prevalence, as well as from hepatitis C virus (HCV), with 1–1.5 % prevalence. Societal ignorance about HBV and HCV in India lim...

    Authors: Partha Sarathi Mukherjee, Eliza Dutta, Dipesh Kr. Das, Shatabdi Ghosh, Suvadip Neogi and Arka Sarkar

    Citation: Hepatology, Medicine and Policy 2016 2:6

    Published on:

  13. Content type: Editorial

    World Hepatitis Day 2016 marks one year since Hepatology, Medicine and Policy (HMAP) began accepting submissions. There have been many major developments in the fight against hepatitis B virus (HBV) and hepatitis...

    Authors: Jeffrey V. Lazarus, Kelly Safreed-Harmon and Mojca Maticic

    Citation: Hepatology, Medicine and Policy 2016 2:4

    Published on:

  14. Content type: Review

    Wilson’s disease is an inherited disorder in which defective biliary excretion of copper leads to its accumulation, particularly in the liver and brain. Mutations in the ATP7B gene on chromosome 13 cause Wilso...

    Authors: Francisco Hevia-Urrutia, Ileana Alvarado-Echeverría, Alfredo Sanabria-Castro, Marta Sánchez-Molina, Luis Meza-Sierra, Alexander Parajeles-Vindas, Oscar Méndez-Blanca, Álvaro Sánchez-Siles, Manuel Saborío-Rocafort, Marcela Barguil-Gallardo, Iliana Chavarría-Quirós and Cecilia Monge-Bonilla

    Citation: Hepatology, Medicine and Policy 2016 2:5

    Published on:

  15. Content type: Research

    Hepatitis B and C are major public health threats in the World Health Organization (WHO) European Region. Viral hepatitis surveillance shortcomings have resulted in many WHO Member States having insufficient d...

    Authors: Jeffrey V. Lazarus, Antons Mozalevskis, Kelly Safreed-Harmon and Irina Eramova

    Citation: Hepatology, Medicine and Policy 2016 1:3

    Published on:

  16. Content type: Research

    The Hepatitis C virus (HCV) is very common among people who inject drugs (PWID), yet PWID in India have suboptimal access to HCV testing and treatment. This study sought to identify HCV risk factors among male...

    Authors: Ruchi Sogarwal, Varada Madge, Pratyush Bishi, Apam Woleng and Rishi Garg

    Citation: Hepatology, Medicine and Policy 2016 1:1

    Published on:

  17. Content type: Research

    More than 17 million people in India are chronically infected with the hepatitis B virus (HBV). Approximately one million of the 26 million children born in India annually will develop chronic HBV infection in...

    Authors: Swati Jha, Divyesh Devaliya, Susan Bergson and Shripad Desai

    Citation: Hepatology, Medicine and Policy 2016 1:5

    Published on:

  18. Content type: Research

    Hepatitis B is an important disease of ethnic disparity which affects Asian Americans and other minority populations disproportionately. Despite the high prevalence of hepatitis B in Asian Americans, many of t...

    Authors: Chul S. Hyun, William R. Ventura, Soon S. Kim, Soyoung Yoon and Seulgi Lee

    Citation: Hepatology, Medicine and Policy 2016 1:6

    Published on:

  19. Content type: Research

    Hepatitis C virus (HCV) imposes a considerable disease burden in China, with at least 10 million people chronically infected. Little is known about the financial impact of the HCV epidemic, nor about the exten...

    Authors: Hai-yang Zhou, Shuang Liu, Su-jun Zheng, Xiao-xia Peng, Yu Chen, Carol Duan, Qing-fen Zheng, Zhao Wang and Zhong-ping Duan

    Citation: Hepatology, Medicine and Policy 2016 1:7

    Published on:

  20. Content type: Research

    Data were obtained from the third National Survey of Knowledge, Attitudes and Practices of HIV and other Sexually Transmitted Infections (STI) (PCAP-2013) and used to describe the current state of viral hepati...

    Authors: Silvano Barbosa de Oliveira, Meritxell Sabidó, Ana Roberta Pati Pascom, Juliana Machado Gisiviez, Adele Schwartz Benzaken and Fábio Mesquita

    Citation: Hepatology, Medicine and Policy 2016 1:3

    Published on:

  21. Content type: Research

    New interferon (IFN)-free treatments for hepatitis C are more effective, safer but more expensive than current IFN-based therapies. Comparative data of these, versus current first generation protease inhibitor...

    Authors: Stephen T. Barclay, Graham S. Cooke, Elizabeth Holtham, Aline Gauthier, Jeremie Schwarzbard, Petar Atanasov and William L. Irving

    Citation: Hepatology, Medicine and Policy 2016 1:2

    Published on:

  22. Content type: Research

    This article describes hepatitis B-related knowledge, attitudes and practices after completion of the Gateway to Care campaign, a citywide public health education program that targeted city residents, health c...

    Authors: Chari Cohen, Alison A. Evans, Peixin Huang, W. Thomas London, Joan M. Block and Gang Chen

    Citation: Hepatology, Medicine and Policy 2016 1:4

    Published on:

Previous Page Page 1 of 2 Next Page